(Q64997010)

3 July 2019

title

Decline in Pneumococcal Disease Attenuated in Older Adults and Those With Comorbidities Following Universal Childhood PCV13 Immunization. (English)

1 reference

3 July 2019

1 reference

1

Stephen I Pelton

1 reference

3 July 2019

author name string

Rebecca Bornheimer

2

1 reference

3 July 2019

Robin Doroff

3

1 reference

3 July 2019

Kimberly M Shea

4

1 reference

3 July 2019

Reiko Sato

5

1 reference

3 July 2019

Derek Weycker

6

1 reference

3 July 2019

language of work or name

English

0 references

publication date

1 May 2019

1 reference

3 July 2019

Clinical Infectious Diseases

published in

1 reference

3 July 2019

volume

68

1 reference

3 July 2019

issue

11

1 reference

3 July 2019

page(s)

1831-1838

1 reference

3 July 2019

Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International

copyright license

start time

20 September 2018

1 reference

April 2022 Public Data File from Crossref

copyright status

copyrighted

0 references

cites work

The influence of chronic illnesses on the incidence of invasive pneumococcal disease in adults

1 reference

12 December 2020

Changing epidemiology of invasive pneumococcal disease among older adults in the era of pediatric pneumococcal conjugate vaccine

1 reference

12 December 2020

Decline in pneumonia admissions after routine childhood immunisation with pneumococcal conjugate vaccine in the USA: a time-series analysis

1 reference

12 December 2020

Incidence of pneumococcal disease due to non-pneumococcal conjugate vaccine (PCV7) serotypes in the United States during the era of widespread PCV7 vaccination, 1998-2004.

1 reference

12 December 2020

National, state, and local area vaccination coverage among children aged 19-35 months--United States, 2007

1 reference

12 December 2020

Prevention of rotavirus gastroenteritis among infants and children: recommendations of the Advisory Committee on Immunization Practices (ACIP).

1 reference

12 December 2020

Identifying individuals with physcian diagnosed COPD in health administrative databases

1 reference

12 December 2020

Sustained reductions in invasive pneumococcal disease in the era of conjugate vaccine

1 reference

12 December 2020

The effect of underlying clinical conditions on the risk of developing invasive pneumococcal disease in England.

1 reference

12 December 2020

Association of diagnostic coding with trends in hospitalizations and mortality of patients with pneumonia, 2003-2009.

1 reference

12 December 2020

Epidemiology of invasive pneumococcal disease among high-risk adults since the introduction of pneumococcal conjugate vaccine for children

1 reference

12 December 2020

Effect of 13-valent pneumococcal conjugate vaccine on admissions to hospital 2 years after its introduction in the USA: a time series analysis

1 reference

12 December 2020

Risk of Pneumococcal Disease in Children With Chronic Medical Conditions in the Era of Pneumococcal Conjugate Vaccine

1 reference

12 December 2020

Effect of use of 13-valent pneumococcal conjugate vaccine in children on invasive pneumococcal disease in children and adults in the USA: analysis of multisite, population-based surveillance

1 reference

12 December 2020

Rates of pneumococcal disease in adults with chronic medical conditions.

1 reference

12 December 2020

Effect of the 13-valent pneumococcal conjugate vaccine on invasive pneumococcal disease in England and Wales 4 years after its introduction: an observational cohort study

1 reference

12 December 2020

Impact of the 13-valent pneumococcal conjugate vaccine (pcv13) on invasive pneumococcal disease and carriage in Alaska

1 reference

12 December 2020

Pneumococcal Vaccination Among Medicare Beneficiaries Occurring After the Advisory Committee on Immunization Practices Recommendation for Routine Use Of 13-Valent Pneumococcal Conjugate Vaccine and 23-Valent Pneumococcal Polysaccharide Vaccine for A

1 reference

12 December 2020

Rapid increase in non-vaccine serotypes causing invasive pneumococcal disease in England and Wales, 2000-17: a prospective national observational cohort study.

1 reference

12 December 2020

Elucidating the impact of the pneumococcal conjugate vaccine programme on pneumonia, sepsis and otitis media hospital admissions in England using a composite control.

1 reference

12 December 2020

Effectiveness of 13-Valent Pneumococcal Conjugate Vaccine Against Hospitalization for Community-Acquired Pneumonia in Older US Adults: A Test-Negative Design.

1 reference

12 December 2020

Identifiers

DOI

10.1093/CID/CIY800

1 reference

3 July 2019

PMC publication ID

6522679

1 reference

3 July 2019

PubMed publication ID

30239637

1 reference

3 July 2019